Danaher Corporation (DHR)vsInotiv Inc (NOTV)
DHR
Danaher Corporation
$187.15
-1.55%
HEALTHCARE · Cap: $134.43B
NOTV
Inotiv Inc
$0.30
-4.09%
HEALTHCARE · Cap: $11.24M
Smart Verdict
WallStSmart Research — data-driven comparison
Danaher Corporation generates 4680% more annual revenue ($24.57B vs $514.03M). DHR leads profitability with a 14.7% profit margin vs -13.5%. DHR earns a higher WallStSmart Score of 60/100 (C).
DHR
Buy60
out of 100
Grade: C
NOTV
Avoid34
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-38.6%
Fair Value
$135.07
Current Price
$187.15
$52.08 premium
Intrinsic value data unavailable for NOTV.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 22.2%
Generating 1.7B in free cash flow
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
4.6% revenue growth
ROE of 7.0% — below average capital efficiency
0.8% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -49.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : DHR
The strongest argument for DHR centers on Market Cap, Price/Book, Operating Margin. PEG of 1.23 suggests the stock is reasonably priced for its growth.
Bull Case : NOTV
The strongest argument for NOTV centers on Price/Book.
Bear Case : DHR
The primary concerns for DHR are P/E Ratio, Revenue Growth, Return on Equity.
Bear Case : NOTV
The primary concerns for NOTV are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
DHR profiles as a value stock while NOTV is a turnaround play — different risk/reward profiles.
NOTV carries more volatility with a beta of 4.22 — expect wider price swings.
DHR is growing revenue faster at 4.6% — sustainability is the question.
DHR generates stronger free cash flow (1.7B), providing more financial flexibility.
Bottom Line
DHR scores higher overall (60/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Danaher Corporation
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Inotiv Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. The company is headquartered in West Lafayette, Indiana.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?